Real-time live tissue sensitivity assay for pancreatic adenocarcinoma
A new research paper titled "Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma" has been published in Oncotarget.
Sep 19, 2023
0
12
A new research paper titled "Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma" has been published in Oncotarget.
Sep 19, 2023
0
12
In the past decade, products bearing "gluten-free" labels have taken grocery store shelves by storm. But for generations of people who learned about food groups from visuals of pyramids with "breads and cereals" as their ...
Sep 14, 2023
0
6
Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to osimertinib alone, according to research presented at the International Association ...
Sep 11, 2023
0
7
Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to platinum and pemetrexed ...
Sep 11, 2023
0
5
The combination of benmelstobart, anlotinib, and chemotherapy demonstrated significant benefits compared to placebo and chemotherapy in terms of median progression-free survival and overall survival for patients with extensive-stage ...
Sep 11, 2023
0
1
The oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity, with a median overall survival of 14.1 months and approximately one in three patients alive at two years, according ...
Sep 9, 2023
0
18
The immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study published in the Sept. 7 issue of the New England Journal ...
Sep 8, 2023
0
26
Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) ...
Sep 1, 2023
0
0
Every basketball coach has told their players at some point that free throws win games. A new study from the University of Kansas used innovative markerless motion capture technology to determine the mechanics of proficient ...
Aug 29, 2023
0
18
The Alliance for Clinical Trials in Oncology today announced that an independent Data and Safety Monitoring Board (DSMB) determined that the phase III CABINET (A021602) pivotal trial met its primary endpoint at an interim ...
Aug 24, 2023
0
19